This combined pathway offers theoretical advantages in weight loss and metabolic health beyond mono-agonist therapies
Your individual result depends on your starting dose, metabolism, genetics, and how well your body responds to the dual GLP-1 and GIP pathway activation
Clinical Trial Results The STEP trials established semaglutide as a breakthrough
~3 months ~3 months From week 5, maintain at 0.5mg / injection Appetite decreases Start seeing weight loss effects (average loss of 3.6%*) ~6 months ~6 months Body feels satisfied with less food Noticeably larger weight loss results (average loss of 5.8%*) How it works Book online Create an account, answer a short medical questionnaire, and talk directly to a counselor, or book an appointment
With the right strategies, you can adjust too and continue making progress
in women, virilisation effects such as deepening voice and hirsutism may occur